• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVaccines

Vaccines

Page 24 of 31
Biden’s national coronavirus strategy is starting to take shape—and it’s very different than Trump’s
PoliticsBiden’s national coronavirus strategy is starting to take shape—and it’s very different than Trump’s
By The Associated Press and Lisa MascaroNovember 28, 2020
Bet on these stocks for the millennial-powered COVID recovery, says Goldman’s Katie Koch
FinanceBet on these stocks for the millennial-powered COVID recovery, says Goldman’s Katie Koch
By Anne SradersNovember 28, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
HealthFor AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
AstraZeneca says its Covid-19 vaccine is up to 90% effective
HealthAstraZeneca says its Covid-19 vaccine is up to 90% effective
By Jeremy KahnNovember 23, 2020
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
NewslettersThe vaccine jolt fades, sinking global stocks—except for this one surprising sector
By Bernhard WarnerNovember 12, 2020
Picture of two syringes on a tray.
HealthU.K. to use A.I. to spot dangerous side effects in the millions of COVID-19 vaccinations it will deliver
By Jeremy KahnNovember 5, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
HealthAstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
COVID vaccine science
HealthThe science behind the leading COVID vaccine candidates
By Sy MukherjeeNovember 3, 2020
CEO of Chinese drugmaker defends his COVID vaccine’s January 2022 timeline
ConferencesCEO of Chinese drugmaker defends his COVID vaccine’s January 2022 timeline
By Naomi Xu ElegantOctober 27, 2020
What will it take for Beijing to meet its climate goals? Changing how it governs entirely
HealthWhat will it take for Beijing to meet its climate goals? Changing how it governs entirely
By Grady McGregorOctober 22, 2020
A masked and gloved healthcare worker holding a syringe.
HealthU.K. drug trial will deliberately expose young people to coronavirus, despite ethical concerns
By Jeremy KahnOctober 21, 2020
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
HealthJ&J CEO still optimistic COVID-19 vaccine could come as early as this year
By Robert HackettOctober 14, 2020
Photo of U.S. Speaker of the House Nancy Pelosi wearing a mask and gesturing with her hands.
HealthA Pelosi snub and a giant federal COVID grant: Another dizzying day in Washington for the U.K.’s AstraZeneca
By Jeremy KahnOctober 12, 2020
Joining WHO’s COVID vaccine program is a chance for China to exploit the U.S.’s absence
HealthJoining WHO’s COVID vaccine program is a chance for China to exploit the U.S.’s absence
By Eamon BarrettOctober 9, 2020
1...
  • 22
  • 23
  • 24
  • 25
  • 26
...31
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.